Viewing nowCombinationDouble Low Tablet 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Il-Yang Pharmaceutical Co., Ltd.

MFDS item code 201702165 · Approved 2017.04.27 · Insurance code 641705320
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively lower and control blood pressure in patients with essential hypertension when blood pressure is not adequately controlled with either amlodipine or telmisartan monotherapy. It helps reduce the risk of cardiovascular complications associated with hypertension. Consistent use is necessary as stable blood pressure management is crucial for maintaining heart and vascular health. This medication plays an important role in blood pressure control and improves the overall health status of patients.
The recommended dose of this drug is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this drug; however, direct switching to this drug may be considered when blood pressure is not adequately controlled with the individual components, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this drug 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. - 80/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or this drug 40/10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this drug (a combination containing the same amounts of each active ingredient) for convenience (limited to this drug 40/5 mg and 80/10 mg). ◦ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ◦ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 mg in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients Requiring Caution’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
◦ Children: The safety and efficacy have not been established in pediatric patients aged 18 years or younger; therefore, administration of this drug is not recommended.
This medication may pose a serious risk to the fetus during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or those who could become pregnant. It should not be administered to patients with allergies to the active ingredient or related ingredients, patients with severe liver dysfunction, patients with left ventricular outflow obstruction, patients with severe hypotension, patients in cardiogenic shock, and patients with unstable heart failure after acute myocardial infarction. Patients with primary aldosteronism, certain heart valve diseases, liver dysfunction, gastrointestinal diseases, renal artery hypertension, dialysis patients, and the elderly should use this medication with caution and particularly when combined with other antihypertensive agents. Side effects such as dizziness and peripheral edema can commonly occur when taking this medication, and serious adverse effects may occur rarely, so if any abnormal symptoms appear, consult a healthcare provider immediately. This medication should not be used during pregnancy; if pregnancy is confirmed, treatment should be discontinued immediately and switched to a safer alternative. Due to the risk of hypotension, patients with volume or salt depletion should manage their condition before taking this medication, and blood pressure should be closely monitored during therapy. There may be a risk of hyperkalemia, so potassium levels should be checked regularly, and caution is needed when taking with potassium supplements. Patients with impaired renal function should frequently monitor renal function and electrolyte levels while on this medication. Patients at risk of myocardial infarction need to be cautious when taking this medication, and dose adjustments and patient status should be closely monitored. It is advisable not to take this medication while breastfeeding, and special attention is needed for children and the elderly. In the case of overdose, hypotension, dizziness, and cardiovascular-related symptoms may occur, so immediate medical treatment is required, and in severe cases, appropriate emergency measures should be taken in a hospital. Store this medication out of reach of children, and take it immediately after opening; it is advisable not to transfer it to another container.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that prevents light from entering. Additionally, it is important to maintain a room temperature between 1 degree and 30 degrees Celsius while storing the medication; this will help preserve its effectiveness.
White or whitish oval tablet
30 tablets (10 tablets/Alu-Alu*3), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Tablet · Prescription medication · Combination
Il-Yang Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.